COSCIENS Biopharma Inc. (TSX:CSCI)

Market Cap	9.36M
Revenue (ttm)	12.61M
Net Income (ttm)	-20.76M
Shares Out	3.18M
EPS (ttm)	-6.58
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,136
Average Volume	3,199
Open	2.900
Previous Close	2.940
Day's Range	2.890 - 2.980
52-Week Range	2.800 - 6.460
Beta	1.45
RSI	48.88
Earnings Date	Mar 25, 2026

About COSCIENS Biopharma

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reduction; beta glucan from yeast, a nutraceutical-capsule used as an immune booster; and avenanthramides, a nutraceutical-chewable formulation used to reduce...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 40
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: CSCI

Financial Performance

In 2024, COSCIENS Biopharma's revenue was $9.59 million, an increase of 34.22% compared to the previous year's $7.14 million. Losses were -$15.31 million, 339.3% more than in 2023.

Financial numbers in USD